Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population an...
Guardado en:
Autores principales: | Bilal Chughtai, Robert Levin, Elise De |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7c20afaace947c19801ad9d191f0c5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Danny Ulahannan, et al.
Publicado: (2009) -
Acupuncture for Treatment of Overactive Bladder
por: Maryam Hosseini, et al.
Publicado: (2021) -
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
por: Makhani A, et al.
Publicado: (2020) -
Overactive bladder: strategies to ensure treatment compliance and adherence
por: Dhaliwal P, et al.
Publicado: (2016) -
Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
por: Magdalena Hagovska, et al.
Publicado: (2021)